New studies shine a light on the effects of a cancer diagnosis on mental health and suicide risk.
by Pamela Rafalow Grossman
As outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared.
by Jon Kelvey
Experts discuss shortcomings of current COVID-19 vaccines in people with cancer while highlighting possibilities of T-cell activation.
by Thomas Celona
Researchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
A symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
An AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.
DNA sequencing found that in many cases when DCIS recurred, the lesion was unrelated to the first diagnosis, raising questions about how to best treat recurrence.
Forward Look
Medical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.
by Erin O'Donnell
Results favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
by Kris Conner
Sooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
Olufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Federal funding could help cancer centers rebuild from the devastating effects of the pandemic.
Learning Medicare’s ABCDs
donate to the AACR